We are live on ! Find out more
PM

Parametrica Management Portfolio holdings

AUM $88M
1-Year Est. Return 48.84%
This Fund
S&P 500
This Quarter Est. Return
+13%
1 Year Est. Return
+48.84%
3 Year Est. Return
+257.17%
5 Year Est. Return
+315.15%
10 Year Est. Return
AUM
$135M
AUM Growth
-$72.6M
Cap. Flow
-$83.8M
Cap. Flow %
-61.9%
Top 10 Hldgs %
44.33%
Holding
205
New
45
Increased
16
Reduced
31
Closed
110

Top Buys

Rank Stock Value
1
BNTX icon
BioNTech
BNTX
+$3.07M
2
STNE icon
StoneCo
STNE
+$2.15M
3
TLRY icon
Tilray
TLRY
+$2.07M
4
CRM icon
Salesforce
CRM
+$2.02M
5
IOVA icon
Iovance Biotherapeutics
IOVA
+$1.93M

Top Sells

Rank Stock Value
1
JD icon
JD.com
JD
+$8.2M
2
NCLH icon
Norwegian Cruise Line
NCLH
+$7.85M
3
TME icon
Tencent Music
TME
+$7.63M
4
NXST icon
Nexstar Media Group
NXST
+$5.3M
5
CVAC
CureVac
CVAC
+$3.97M

Sector Composition

Rank Sector Weight
1 Communication Services 28.24%
2 Consumer Discretionary 21.22%
3 Healthcare 18.41%
4 Technology 17.13%
5 Industrials 5.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WIX icon
76
WIX.com
WIX
$2.56B
$224K 0.17%
772
-2,136
-73% -$599K
GPN icon
77
Global Payments
GPN
$24.1B
$220K 0.16%
+1,171
New +$236K
CRON
78
Cronos Group
CRON
$1.07B
$217K 0.16%
25,253
+6,132
+32% +$50.7K
XP icon
79
XP
XP
$8.43B
$217K 0.16%
4,988
-3,279
-40% -$136K
MAXR
80
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$213K 0.16%
+5,340
New +$190K
HOME
81
DELISTED
At Home Group Inc.
HOME
$213K 0.16%
+5,785
New +$197K
LVS icon
82
Las Vegas Sands
LVS
$31.4B
$211K 0.16%
+3,996
New +$231K
YUM icon
83
Yum! Brands
YUM
$41.9B
$210K 0.16%
+1,826
New +$215K
ZBH icon
84
Zimmer Biomet
ZBH
$18.8B
$207K 0.15%
+1,326
New +$215K
AVYA
85
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
$202K 0.15%
+7,483
New +$210K
TXN icon
86
Texas Instruments
TXN
$248B
$201K 0.15%
+1,046
New +$196K
COTY icon
87
Coty
COTY
$2.4B
$199K 0.15%
+21,253
New +$193K
GT icon
88
Goodyear
GT
$2.09B
$190K 0.14%
+11,070
New +$204K
YEXT icon
89
Yext
YEXT
$573M
$153K 0.11%
+10,696
New +$149K
KPTI icon
90
Karyopharm Therapeutics
KPTI
$155M
$139K 0.1%
898
-5,295
-85% -$768K
GNW icon
91
Genworth Financial
GNW
$3.86B
$123K 0.09%
31,555
-40,282
-56% -$161K
ADT icon
92
ADT
ADT
$5.43B
$114K 0.08%
+10,590
New +$106K
CVE icon
93
Cenovus Energy
CVE
$54.2B
$100K 0.07%
10,480
-15,510
-60% -$131K
FSM icon
94
Fortuna Silver Mines
FSM
$2.54B
$88K 0.07%
+15,756
New +$104K
ENDP
95
DELISTED
Endo International plc
ENDP
$67K 0.05%
+14,254
New +$81.7K
A icon
96
Agilent Technologies
A
$39.6B
-2,096
Closed -$262K
ADI icon
97
Analog Devices
ADI
$172B
-8,983
Closed -$1.37M
AEE icon
98
Ameren
AEE
$30.4B
-2,573
Closed -$209K
AES icon
99
AES
AES
$10.6B
-13,152
Closed -$354K
ALB icon
100
Albemarle
ALB
$13.4B
-2,484
Closed -$362K

Similar funds

Parametrica Management's Q2 2021 Portfolio in Review

As of Q2 2021, Parametrica Management held 205 positions worth $135M, down 35% from $208M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Parametrica Management withdrew a net $83.8M in Q2 2021, closing 110 positions and reducing 31 holdings. Its most notable exit was CureVac, an estimated $3.97M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 28% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Parametrica Management opened a new position in Tilray worth $2.13M.

  • Parametrica Management's largest Q2 2021 buy was Tilray: 11,809 shares worth $2.13M.
  • Parametrica Management added most to BioNTech in Q2 2021, an estimated $3.07M increase.
  • Parametrica Management's biggest Q2 2021 reduction was JD.com, cutting an estimated $8.2M.
  • Parametrica Management fully exited CureVac in Q2 2021, selling an estimated $3.97M.
  • Parametrica Management's ten largest holdings make up 44% of its $135M portfolio in Q2 2021.
  • Parametrica Management opened 45 new positions and closed 110 in Q2 2021.
  • Parametrica Management's portfolio value fell 35% quarter-over-quarter to $135M.

Based on Parametrica Management's 13F filing for Q2 2021, filed 13 Aug 2021.